Keyphrases
Adjusted Relative Risk
10%
Admission to Hospital
10%
AIMS™
10%
Celecoxib
10%
Confidence Interval
10%
Congestive Heart Failure
100%
Cyclooxygenase-2 Inhibitors
100%
Drug Exposure
10%
Heart Failure
10%
Hospital Admission
10%
Hospitalization
30%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Odds Ratio
10%
Potential Confounders
10%
Primary Diagnosis
10%
Relative Risk
20%
Risk Dilution
10%
Rofecoxib
10%
Structured Interview
10%
Vulnerable People
10%
Medicine and Dentistry
Case-Control Study
10%
Celecoxib
10%
Congestive Heart Failure
100%
Cyclooxygenase 2 Inhibitor
100%
Drug Exposure
10%
Nonsteroid Antiinflammatory Agent
100%
Odds Ratio
10%
Rofecoxib
10%
Pharmacology, Toxicology and Pharmaceutical Science
Case-Control Study
10%
Celecoxib
10%
Congestive Heart Failure
100%
COX-2 Inhibitor
100%
Non-Steroidal Anti-Inflammatory Drug
100%
Rofecoxib
10%
Biochemistry, Genetics and Molecular Biology
Anti-Inflammatory
100%
Case-Control Study
10%
Celecoxib
10%
COX-2 Inhibitor
100%
Dilution
10%
Drug Exposure
10%
Rofecoxib
10%